240 related articles for article (PubMed ID: 25093186)
1. Phytochemicals: a multitargeted approach to gynecologic cancer therapy.
Farrand L; Oh SW; Song YS; Tsang BK
Biomed Res Int; 2014; 2014():890141. PubMed ID: 25093186
[TBL] [Abstract][Full Text] [Related]
2. The innate effects of plant secondary metabolites in preclusion of gynecologic cancers: Inflammatory response and therapeutic action.
Garg P; Awasthi S; Horne D; Salgia R; Singhal SS
Biochim Biophys Acta Rev Cancer; 2023 Jul; 1878(4):188929. PubMed ID: 37286146
[TBL] [Abstract][Full Text] [Related]
3. Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance.
Mortazavi H; Nikfar B; Esmaeili SA; Rafieenia F; Saburi E; Chaichian S; Heidari Gorji MA; Momtazi-Borojeni AA
Eur J Med Chem; 2020 Feb; 187():111951. PubMed ID: 31821990
[TBL] [Abstract][Full Text] [Related]
4. Phytochemicals in Gynecological Cancer Prevention.
Woźniak M; Krajewski R; Makuch S; Agrawal S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530651
[TBL] [Abstract][Full Text] [Related]
5. Combating breast cancer using combination therapy with 3 phytochemicals: Piperine, sulforaphane, and thymoquinone.
Aumeeruddy MZ; Mahomoodally MF
Cancer; 2019 May; 125(10):1600-1611. PubMed ID: 30811596
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for gynecologic cancers.
Rahaman J; Steiner N; Hayes MP; Chuang L; Fishman D; Gretz Iii H
Mt Sinai J Med; 2009 Dec; 76(6):577-88. PubMed ID: 20014427
[TBL] [Abstract][Full Text] [Related]
7. New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP Inhibitors.
Liu FW; Tewari KS
Curr Treat Options Oncol; 2016 Mar; 17(3):12. PubMed ID: 26931795
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive profiling of EGFR/HER receptors for personalized treatment of gynecologic cancers.
Reyes HD; Thiel KW; Carlson MJ; Meng X; Yang S; Stephan JM; Leslie KK
Mol Diagn Ther; 2014 Apr; 18(2):137-51. PubMed ID: 24403167
[TBL] [Abstract][Full Text] [Related]
9. Recent surgical approaches to gynecologic oncology.
Duffy MS
Nurs Clin North Am; 2001 Sep; 36(3):603-15, xii. PubMed ID: 11532673
[TBL] [Abstract][Full Text] [Related]
10. Current Progress of Phytomedicine in Glioblastoma Therapy.
Shah FH; Salman S; Idrees J; Idrees F; Shah STA; Khan AA; Ahmad B
Curr Med Sci; 2020 Dec; 40(6):1067-1074. PubMed ID: 33428134
[TBL] [Abstract][Full Text] [Related]
11. Metastatic gynecologic malignancies: advances in treatment and management.
Chan JK; Chow S; Bhowmik S; Mann A; Kapp DS; Coleman RL
Clin Exp Metastasis; 2018 Aug; 35(5-6):521-533. PubMed ID: 29931499
[TBL] [Abstract][Full Text] [Related]
12. Phytochemicals: Current strategy to sensitize cancer cells to cisplatin.
Sun CY; Zhang QY; Zheng GJ; Feng B
Biomed Pharmacother; 2019 Feb; 110():518-527. PubMed ID: 30530287
[TBL] [Abstract][Full Text] [Related]
13. Quality of life and mood in women receiving extensive chemotherapy for gynecologic cancer.
Lutgendorf SK; Anderson B; Rothrock N; Buller RE; Sood AK; Sorosky JI
Cancer; 2000 Sep; 89(6):1402-11. PubMed ID: 11002237
[TBL] [Abstract][Full Text] [Related]
14. Potential of nano-phytochemicals in cervical cancer therapy.
Yadav N; Parveen S; Banerjee M
Clin Chim Acta; 2020 Jun; 505():60-72. PubMed ID: 32017926
[TBL] [Abstract][Full Text] [Related]
15. Rationale and clinical experience with epidermal growth factor receptor inhibitors in gynecologic malignancies.
Vaidya AP; Parnes AD; Seiden MV
Curr Treat Options Oncol; 2005 Mar; 6(2):103-14. PubMed ID: 15717992
[TBL] [Abstract][Full Text] [Related]
16. Comparison between tumors in plants and human beings: Mechanisms of tumor development and therapy with secondary plant metabolites.
Ullrich CI; Aloni R; Saeed MEM; Ullrich W; Efferth T
Phytomedicine; 2019 Nov; 64():153081. PubMed ID: 31568956
[TBL] [Abstract][Full Text] [Related]
17. Chemoresistance in Ovarian Cancer: Prospects for New Drugs.
Tendulkar S; Dodamani S
Anticancer Agents Med Chem; 2021; 21(6):668-678. PubMed ID: 32900355
[TBL] [Abstract][Full Text] [Related]
18. Enhancing Care of the Survivor of Gynecologic Cancer: Managing the Menopause and Radiation Toxicity.
Van Le L; McCormack M
Am Soc Clin Oncol Educ Book; 2016; 35():e270-5. PubMed ID: 27249732
[TBL] [Abstract][Full Text] [Related]
19. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.
Muggia FM
Semin Oncol; 2004 Dec; 31(6 Suppl 14):17-24. PubMed ID: 15726530
[TBL] [Abstract][Full Text] [Related]
20. Wanna Get Away? Maintenance Treatments and Chemotherapy Holidays in Gynecologic Cancers.
Madariaga A; Rustin GJS; Buckanovich RJ; Trent JC; Oza AM
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e152-e166. PubMed ID: 31099646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
